Skip to main content

Table 2 Frequency of multiple autoantibodies in 100 patients with autoimmune myositis

From: Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes

Additional antibodiesa

Autoantibodies

Patients (total)

 

Ku (n = 23)

tRNA (n = 22)

U1RNP (n = 15)

Fibrillarin (n = 14)

PM-Scl (n = 9)

SSc (n = 9)

NUP (n = 3)

SRP (n = 2)

Ro (n = 31)

La (n = 14)

Mi-2 (n = 6)

No antibody (n = 20)

= 1 antibody (n = 80)

None

7 (31)

4 (18)

6 (40)

1 (7)

2 (22)

1 (11)

2 (67)

2 (100)

4 (13)

3 (21)

3 (50)

0

36 (36)b

1 more

7 (31)

8 (36)

6 (40)

4 (28)

4 (44)

3 (33)

1 (33)

0

12 (39)

4 (29)

2 (33)

0

26 (26)

2 more

5 (21)

6 (28)

2 (13)

6 (43)

1 (12)

3 (33)

0

0

10 (32)

4 (29)

0

0

12 (12)

≥3 more

4 (17)

4 (18)

1 (7)

3 (22)

2 (22)

2 (23)

0

0

5 (16)

3 (21)

1 (17)

0

6 (6)

  1. Values are expressed as number (%). tRNA synthetases (tRNA) include Jo-1, PL-7, PL-12, and KS. Systemic sclerosis (SSc) autoantigens include topoisomerase I, RNA polymerase III, centromere protein B, and Th. aCategories are mutually exclusive. bIncludes an additional patient who had anti-U5RNP (not shown). NUP, nucleoporins; RNP, ribonucleoprotein; SRP = signal recognition particle.